运动创伤治疗技术与器械教育部工程研究中心于2022年由中华人民共和国教育部批准立项建设，依托北京大学，整合北京大学运动医学研究所（北京大学第三医院运动医学科）及校内相关院系的优势资源。北京大学运动医学研究所是中国运动医学的发源地，是教育部唯一的运动医学国家重点学科、中国奥委会指定运动员伤病防治中心。在此基础上，中心成为我国运动医学领域首个集临床诊疗、基础研究、器械研发、成果转化及人才培养于一体的国家级工程研究中心。

中心以“健康中国”和“全民健身”国家战略为指引，聚焦运动创伤治疗技术创新难、转化速度慢、进口依赖大、国产器械弱等核心问题，致力于构建“临床需求牵引—基础研究驱动—医工融合转化”的创新平台体系。主要研究方向包括：微创手术器械、仿生植入类器械、智能康复器械及远程康复系统。

中心拥有一流的研究团队，中心主任为王健全教授，技术带头人包括敖英芳、崔国庆、郭秦炜、江东等国内运动医学领域顶尖专家。团队现有教授、主任医师、研究员等骨干成员20余人，其中多人担任中华医学会运动医疗分会主任委员、国家体育总局奥运医疗专家等国家级学术职务。

中心具备完善的科研创新平台和雄厚的转化实力。建设期内，累计发表SCI论文150余篇，申请国家专利80余项，授权45项，完成成果转化8项，转化金额超1500万元，获省部级科技奖励多项。目前承担国家重点研发计划、国家自然科学基金等国家级省部级课题30余项，已完成国家级省部级课题100余项。同时，与德美医疗、纳通医疗、华为终端、小米科技等20余家企业建立深度合作，共建联合研发中心，推动创新产品快速落地。

中心近年来的重要科研成果及贡献有：

首创嵌入式喙突移位手术（Cuistow）并研发配套器械，灵感源于中国传统榫卯结构，获批专利10余项，完成1000万元成果转化，相关术式获2024年北京市科技进步二等奖，入选“中国骨科十大临床诊疗新进展”。

研发可降解锌合金植入物，实现高强度与适宜降解速率的协同突破，相关研究发表于《Advanced Materials》（IF=27.4），为可降解金属临床转化提供关键支撑。

构建“评估—训练—评价”一体化远程康复云平台，集成700余个医学级训练动作库与300余个标准化运动处方库，已在全国140余家医院示范应用，服务患者超10万人次。

研发首款髌骨脱位专用智能支具，完成200万元转化，已正式上市销售；智能膝限位支具、抗剪力支具等多款产品进入临床试用阶段。

在踝关节微创器械领域，系统研发距骨钻孔器械、微创取骨植骨器械、韧带修复固定系统等，获批多项发明专利，相关技术发表于《Journal of Orthopaedic Translation》等权威期刊。

面向未来，中心将继续以国家重大健康需求为导向，深耕微创手术机器人、可降解植入材料、智能康复外骨骼等前沿领域，推动我国运动创伤治疗技术与器械从“国产替代”迈向“国际引领”，为健康中国和体育强国建设作出更大贡献。

机构负责人：王健全

联系人：江东

邮箱：dong_jiang@bjmu.edu.cn

电话：010-82074373

地址：北京市海淀区花园北路49号

Engineering Research Center for Sports Injury Treatment Technology and Devices, Ministry of Education

The Engineering Research Center for Sports Injury Treatment Technology and Devices was established in 2022 with the approval of the Ministry of Education of China. Based at Peking University, it integrates the strengths of the Peking University Institute of Sports Medicine (Department of Sports Medicine, Peking University Third Hospital) and related university departments. As the birthplace of sports medicine in China, Peking University Institute of Sports Medicine is the only National Key Discipline of Sports Medicine under the Ministry of Education and the designated athlete injury treatment center of the Chinese Olympic Committee. Building on this foundation, the Center has become the first national-level engineering research center in China’s sports medicine field, integrating clinical care, fundamental research, device development, technology translation, and talent cultivation.

Guided by the national strategies of “Healthy China” and the “National Fitness Program,” the Center addresses critical challenges such as slow innovation in treatment technologies, low translation efficiency, heavy reliance on imported devices, and underdeveloped domestic medical equipment. Its mission is to build an innovative platform that integrates clinical needs, fundamental research, and med-tech convergence. The main research directions include minimally invasive surgical instruments, biomimetic implantable devices, and intelligent rehabilitation equipment with remote rehabilitation systems.

The Center boasts a first-class research team. The director is Professor Wang Jianquan, and the technical leaders include renowned experts in sports medicine such as Ao Yingfang, Cui Guoqing, Guo Qinwei, and Jiang Dong. The team comprises over 20 core members including professors, chief physicians, and principal investigators, many of whom hold national academic positions such as Chair of the Sports Medicine Branch of the Chinese Medical Association and medical experts for the Olympic Games of the General Administration of Sport of China.

The Center has a well-established platform for scientific innovation and technology translation. During the construction period, it has published over 150 SCI-indexed papers, filed more than 80 national patents, and been granted 45 patents. It has completed eight technology transfers with a total value exceeding 15 million RMB and received multiple provincial and ministerial-level science and technology awards. Currently, it undertakes more than 30 national and provincial research projects, including the National Key R&D Program and NSFC projects, and has completed over 100 such projects. In addition, the Center has established deep collaborations with more than 20 enterprises, including Deme Medical, Naton Medical, Huawei Terminal, and Xiaomi Technology, co-building R&D centers to accelerate the translation of innovative products.

Major achievements and contributions in recent years:

Pioneered the embedded coracoid transfer procedure (Cuistow) and developed specialized instruments inspired by traditional Chinese mortise-tenon structures. This innovation has been granted over 10 patents and achieved a technology transfer of 10 million RMB. The procedure was awarded the Second Prize of Beijing Science and Technology Progress Award in 2024 and was selected as one of the “Top Ten New Advances in Clinical Diagnosis and Treatment in Chinese Orthopedics.”

Developed biodegradable zinc alloy implants achieving a breakthrough in balancing high strength and suitable degradation rate. Related research was published in Advanced Materials (IF=27.4), providing critical support for the clinical translation of biodegradable metals.

Established an integrated remote rehabilitation cloud platform featuring “assessment-training-evaluation,” incorporating over 700 medical-grade exercise movements and 300 standardized exercise prescriptions. The platform has been demonstrated in more than 140 hospitals nationwide, serving over 100,000 patients.

Developed the first intelligent patellar dislocation-specific brace, completed a 2 million RMB technology transfer, and launched it into the market. Multiple products such as intelligent knee motion-limiting braces and anti-shear braces are in clinical trials.

Systematically developed a series of minimally invasive ankle instruments, including talar drilling devices, minimally invasive bone harvesting and grafting instruments, and ligament repair fixation systems, with multiple invention patents granted. Related technologies have been published in prestigious journals such as the Journal of Orthopaedic Translation.

Looking ahead, the Center will continue to address major national health needs, advancing cutting-edge fields such as minimally invasive surgical robotics, biodegradable implant materials, and intelligent rehabilitation exoskeletons. It aims to lead the transformation of China’s sports injury treatment technologies and devices from “domestic substitution” to “global leadership,” contributing significantly to the Healthy China and Sports Power strategies.

Director: Prof. Wang Jianquan

Contact: Dr. Jiang Dong

Email: dong_jiang@bjmu.edu.cn

Tel: 010-82074373

Address: No. 49 Huayuan North Road, Haidian District, Beijing, China